Semaglutide is gaining traction as a novel treatment for chronic diseases. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to produce more insulin and reducing glucagon https://keziaatwm141952.webdesign96.com/36169824/understanding-semaglutide-a-comprehensive-guide